| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |